Article info

Download PDFPDF
How dangerous are norovirus infections in patients with rheumatic diseases treated with biologics and DMARDs? Follow-up on a local outbreak and comparison with a control cohort

Authors

  1. Correspondence to Professor Christoph Fiehn, ACURA Center for Rheumatic Diseases, Rotenbachtalstr. 5, Baden-Baden 76530, Germany; c.fiehn{at}acura-kliniken.com
View Full Text

Citation

Fiehn C, Miehle N
How dangerous are norovirus infections in patients with rheumatic diseases treated with biologics and DMARDs? Follow-up on a local outbreak and comparison with a control cohort

Publication history

  • Received August 12, 2013
  • Revised September 27, 2013
  • Accepted November 5, 2013
  • First published November 25, 2013.
Online issue publication 
February 27, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.